Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
02/2009
02/18/2009EP1208097B1 Substituted oxoazaheterocyclyl compounds
02/18/2009CN101370793A Novel N-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor CCR4
02/18/2009CN101370779A Cyclohexyl sulfonamide derivatives having H3 receptor activity
02/18/2009CN101367748A Amide derivatives, process for production of the same, and method for application thereof as insecticide
02/17/2009US7491741 Diaminopropionic acid derivatives
02/17/2009US7491724 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
02/17/2009US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use
02/17/2009US7491720 antitumor agent; 6-((4-(2-fluoro-3-(trifluoromethyl)benzoyl)piperazin-1-yl)methyl)-N-1H-pyrazol-3-ylpyrazin-2-amine; excellent potentiation; side effects reduction
02/17/2009US7491718 Aminopeptidase inhibitor; vision defects; administering to eye
02/12/2009WO2008152073A3 Piperazine compounds with a herbicidal action
02/12/2009WO2008152072A3 Piperazine compounds with a herbicidal action
02/12/2009WO2007134169A3 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
02/12/2009US20090043099 Methods and compositions for derepression of IAP-inhibited caspase
02/12/2009US20090042904 Substituted Phenly-Piperazine Compounds, Their Preparation And Use In Medicaments
02/12/2009US20090042899 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
02/12/2009US20090042883 Antitumor agent
02/12/2009US20090042881 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/12/2009US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
02/12/2009US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control
02/12/2009CA2699461A1 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
02/11/2009EP2022786A1 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep
02/11/2009EP1640402B1 Diamine having quinoxaline unit, polyimide precursor, polyimide and use thereof
02/11/2009CN101365687A Piperazine compounds with a herbicidal action
02/11/2009CN101362725A Method for preparing tetramethylpyrazine guanidine derivatives and application thereof
02/11/2009CN101362724A Tetramethylpyrazine acidamides derivates, preparation method and medicament composition and application
02/11/2009CN100460412C Process for preparing amine platinum complexes
02/11/2009CN100460397C Sulfur-containing quinoxaline dioxide, method for producing same and their application in preparing low-oxygen selective anti-tumor medicament
02/05/2009WO2009018405A1 Integrated photoactive agents and uses thereof
02/05/2009WO2009018065A2 Novel glucokinase activators and methods of using same
02/05/2009WO2009016841A1 Oxopyrazine derivative and herbicide
02/05/2009US20090036457 Utilities of olefin derivatives
02/05/2009US20090036456 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
02/05/2009US20090036455 Arylpiperazine derivative and use thereof as 5-ht1a receptor ligands
02/05/2009US20090036444 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor
02/05/2009US20090033210 Compound and organic light emitting device
02/05/2009CA2695197A1 Integrated photoactive agents and uses thereof
02/05/2009CA2694882A1 Oxopyrazine derivative and herbicide
02/04/2009EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
02/04/2009CN100457739C Dentritic pattern compound, preparation method and application
02/04/2009CN100457738C Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives
02/04/2009CN100457735C Therapeutic agents useful for treating pain
02/04/2009CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
02/03/2009US7485646 Serotonin 5-HT3 receptor agonist
02/03/2009US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation
01/2009
01/29/2009WO2008107211A3 Novel p2y12 receptor antagonists
01/29/2009WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
01/29/2009US20090030205 Process for obtaining cetirizine dihydrochloride
01/29/2009US20090030176 2,3-di(2-thienyl)-5-(4-aminophenyl)-aminoquinoxaline; N-4-aminophenyl-10-aminodibenzo(A,C)phenazine; polyamines obtained by polymerizing the aminoquinoxaline compound; poly{2,3-diphenyl-5-(4-aminophenyl)-aminoquinoxaline; films, solar cell, oraganic light emitter; semiconductor
01/29/2009US20090030008 Piperazine derivatives and their use as therapeutic agents
01/29/2009US20090030007 crystalline form of trans-1 {4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}-3,3-dimethyl-urea hydrochloride (Form III) Cariprazine {RGH-188); Dysfunction of the dopaminergic neurotransmitter system is involved in the pathology of several neuropsychiatric and neurodegenerative disorders
01/29/2009US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors
01/29/2009US20090029971 4-[2,6-Dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury
01/29/2009US20090026919 Phenanthrene derivative
01/29/2009CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity
01/28/2009EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
01/28/2009CN101353324A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
01/28/2009CN100455565C Sulfonamide anions as catalysts for nco oligomerization
01/27/2009US7482466 Hydroxamates as therapeutic agents
01/27/2009US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay
01/27/2009US7482357 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease
01/27/2009US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists
01/22/2009WO2009010429A2 Novel heterocyclyl compounds and their use as chemokine antagonists
01/22/2009WO2009010156A2 Substituted phenylpropoargyl compounds, methods for the production thereof, and use of same as herbicides and plant growth regulators
01/22/2009US20090023925 N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles
01/22/2009US20090023774 Pyridine analogs as C5A antagonists
01/22/2009US20090023741 Aryl/hetarylamides as modulators of the ep2 receptor
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009US20090023721 Novel Substituted Tetracyclic Tetrahydrofuran, Pyrrolidine and Tetrahydrothiophene Derivatives and Their Use as a Medicament
01/22/2009US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives
01/22/2009US20090023711 Piperazines and Piperidines as Mglur5 Potentiators
01/22/2009CA2695998A1 Novel heterocyclyl compounds
01/21/2009EP2017264A1 Substituted phenyl propargyl compounds, method for their manufacture and their use as herbicides and plant growth regulators
01/21/2009CN101351454A Pyrazine derivatives and uses thereof in renal monitoring
01/21/2009CN101351451A Multicyclic amino acid derivatives and methods of their use
01/20/2009US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
01/20/2009US7479493 e.g. [4-(3,4-Dichloro-phenoxy)-3-methylaminomethyl-phenyl]-(4-isopropyl-piperazin-1-yl)-methanone; histamine H3 receptor and/or serotonin transporter modulator; antidepressant; cognitive disorders, sleep disorders, psychiatric disorders, drug abuse, sexual dysfunction
01/20/2009CA2502856C Intermediates for retroviral protease inhibiting compounds
01/15/2009WO2009009501A2 Non-basic melanin concentrating hormone receptor-1 antagonists and methods
01/15/2009WO2009007396A1 Nonsteroidal progesterone receptor modulators
01/15/2009WO2008125342A3 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
01/15/2009US20090018337 Process for the preparation of a pharmaceutical intermediate
01/15/2009US20090018144 Capped pyrazinoylguanidine sodium channel blockers
01/15/2009US20090018141 Kinase inhibitors, compositions thereof, and methods of use therewith
01/15/2009US20090018056 Heteroarylcarbamoylbenzene derivatives
01/15/2009US20090017489 Methods For Modulating The Development Of Dopamine Neuron By The Dopamine D2 Receptor And Compositions Thereof
01/15/2009CA2692671A1 Non-basic melanin concentrating hormone receptor-1 antagonists and methods
01/14/2009EP2014291A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
01/14/2009EP2014285A1 NPYY5 antagonists
01/14/2009EP2013171A1 Piperidines and related compounds for treatment of alzheimer s disease
01/14/2009EP1663974B1 2-pyridone derivatives as netrophil elastase inhibitors and their use
01/14/2009CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
01/14/2009CN100451006C Carboxyl acylamide compound and its preparing method and use
01/14/2009CN100451005C Deoxyneohydroxyaspergillic acid and its prepn and use
01/13/2009US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology
01/13/2009US7476465 High density; stability; n-heterocyclic polymer or oligomer
01/08/2009WO2009005671A2 Substituted piperazines as cb1 antagonists
01/08/2009WO2009005646A2 Substituted piperazines as cb1 antagonists
01/08/2009WO2009005645A1 Substituted piperazines as cb1 antagonists
01/08/2009WO2009005460A1 Small molecule inhibitors of navl.7 sodium channels for the treatment of pain disorders
01/08/2009WO2009004430A1 N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 187